Martin J Emerson
CIK 1230453 · President and CEO · last filed 2026-04-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
21
Lifetime Open-Market Net
-$758.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NUWE | Director | — | $0.14 | — | $0 | 1 | 2026-04-29 |
| VASCULAR SOLUTIONS INC (VASC) Delisted | Director | 8,435 | — | — | -$758.6K | 7 | 2016-05-16 |
| WRIGHT MEDICAL GROUP INC (WMGI.Z) Delisted | Director | 0 | — | — | $0 | 2 | 2015-10-05 |
| LIFECORE BIOMEDICAL INC (LCBM) Delisted | Director | — | — | — | $0 | 2 | 2008-03-27 |
Recent Filings · Page 3 of 3
21 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-02-13 | — | Grant (A) | — | $0 |
Showing 21–21 of 21
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.